Cluster composition

Functions

CategoryNameIntersectionWithQueryPValueGenesInTermGenesInQueryGenesInTermInQueryID
GeneOntologyMolecularFunctionFc-gamma receptor I complex binding

IGHG2 IGHG3

1.49e-047542GO:0034988
GeneOntologyMolecularFunctionmetallopeptidase activity

ADAMTS12 ADAMTS10 AEBP1 XPNPEP3 MMP15

2.04e-04200545GO:0008237
GeneOntologyBiologicalProcesspositive regulation of immunoglobulin mediated immune response

IGHG2 IGHG3 EXOSC6 HPX

9.43e-0656494GO:0002891
GeneOntologyBiologicalProcesspositive regulation of B cell mediated immunity

IGHG2 IGHG3 EXOSC6 HPX

9.43e-0656494GO:0002714
GeneOntologyBiologicalProcessregulation of immunoglobulin mediated immune response

IGHG2 IGHG3 EXOSC6 HPX

3.70e-0579494GO:0002889
GeneOntologyBiologicalProcessregulation of B cell mediated immunity

IGHG2 IGHG3 EXOSC6 HPX

3.70e-0579494GO:0002712
GeneOntologyBiologicalProcesspositive regulation of type I hypersensitivity

IGHG2 IGHG3

1.53e-048492GO:0001812
GeneOntologyBiologicalProcessregulation of type I hypersensitivity

IGHG2 IGHG3

1.97e-049492GO:0001810
GeneOntologyBiologicalProcesspositive regulation of type II hypersensitivity

IGHG2 IGHG3

2.46e-0410492GO:0002894
GeneOntologyBiologicalProcesspositive regulation of type IIa hypersensitivity

IGHG2 IGHG3

2.46e-0410492GO:0001798
GeneOntologyBiologicalProcesstype I hypersensitivity

IGHG2 IGHG3

2.46e-0410492GO:0016068
GeneOntologyBiologicalProcessregulation of type II hypersensitivity

IGHG2 IGHG3

3.00e-0411492GO:0002892
GeneOntologyBiologicalProcessregulation of type IIa hypersensitivity

IGHG2 IGHG3

3.00e-0411492GO:0001796
GeneOntologyBiologicalProcessantibody-dependent cellular cytotoxicity

IGHG2 IGHG3

4.24e-0413492GO:0001788
GeneOntologyBiologicalProcesshumoral immune response mediated by circulating immunoglobulin

IGHG2 IGHG3 HPX

4.32e-0462493GO:0002455
GeneOntologyBiologicalProcesspositive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains

IGHG2 IGHG3 EXOSC6 HPX

4.41e-04150494GO:0002824
GeneOntologyBiologicalProcesspositive regulation of lymphocyte mediated immunity

IGHG2 IGHG3 EXOSC6 HPX

4.41e-04150494GO:0002708
GeneOntologyBiologicalProcessRNA catabolic process

CASC3 YBX2 RNASE2 SMG7 RBM33 EXOSC6

5.32e-04432496GO:0006401
GeneOntologyBiologicalProcesspositive regulation of adaptive immune response

IGHG2 IGHG3 EXOSC6 HPX

5.50e-04159494GO:0002821
GeneOntologyBiologicalProcesspositive regulation of hypersensitivity

IGHG2 IGHG3

5.69e-0415492GO:0002885
GeneOntologyBiologicalProcesstype IIa hypersensitivity

IGHG2 IGHG3

5.69e-0415492GO:0001794
GeneOntologyBiologicalProcesstype II hypersensitivity

IGHG2 IGHG3

5.69e-0415492GO:0002445
GeneOntologyBiologicalProcesspositive regulation of acute inflammatory response to antigenic stimulus

IGHG2 IGHG3

7.35e-0417492GO:0002866
GeneOntologyBiologicalProcessnucleic acid catabolic process

CASC3 YBX2 RNASE2 SMG7 RBM33 EXOSC6

7.73e-04464496GO:0141188
GeneOntologyBiologicalProcesspositive regulation of leukocyte mediated immunity

IGHG2 IGHG3 EXOSC6 HPX

7.88e-04175494GO:0002705
GeneOntologyBiologicalProcessregulation of hypersensitivity

IGHG2 IGHG3

9.21e-0419492GO:0002883
GeneOntologyCellularComponentdendrite

CASC3 MAP6 CYP11B1 IGSF9B PLEC CTNND1 BSN DENND1A ARHGEF15

1.75e-04858509GO:0030425
GeneOntologyCellularComponentdendritic tree

CASC3 MAP6 CYP11B1 IGSF9B PLEC CTNND1 BSN DENND1A ARHGEF15

1.78e-04860509GO:0097447
GeneOntologyCellularComponenthemidesmosome

ITGA6 PLEC

3.04e-0411502GO:0030056
GeneOntologyCellularComponentblood microparticle

FN1 IGHG2 IGHG3 HPX

3.89e-04144504GO:0072562
GeneOntologyCellularComponentIgG immunoglobulin complex

IGHG2 IGHG3

5.01e-0414502GO:0071735
GeneOntologyCellularComponentimmunoglobulin complex, circulating

IGHG2 IGHG3

7.45e-0417502GO:0042571
GeneOntologyCellularComponentextracellular matrix

ADAMTS12 ADAMTS10 FN1 AEBP1 HPX ITGA6 MMP15

8.97e-04656507GO:0031012
GeneOntologyCellularComponentexternal encapsulating structure

ADAMTS12 ADAMTS10 FN1 AEBP1 HPX ITGA6 MMP15

9.13e-04658507GO:0030312
GeneOntologyCellularComponentpresynaptic active zone cytoplasmic component

CTNND1 BSN

1.37e-0323502GO:0098831
GeneOntologyCellularComponentsomatodendritic compartment

CASC3 MAP6 CYP11B1 IGSF9B PLEC CTNND1 BSN DENND1A ARHGEF15

2.28e-031228509GO:0036477
GeneOntologyCellularComponentinhibitory synapse

IGSF9B BSN

2.49e-0331502GO:0060077
HumanPhenoCongenital pyloric atresia

ITGA6 PLEC

2.10e-053142HP:0004399
DomainPTBI

FRS3 DOK2

3.96e-0411512SM00310
DomainIRS_PTB

FRS3 DOK2

4.74e-0412512PS51064
DomainIRS_PTB

FRS3 DOK2

6.51e-0414512IPR002404
DomainIRS

FRS3 DOK2

6.51e-0414512PF02174
DomainHemopexin_CS

HPX MMP15

9.68e-0417512IPR018486
DomainPLAC

ADAMTS12 ADAMTS10

1.21e-0319512IPR010909
DomainPLAC

ADAMTS12 ADAMTS10

1.21e-0319512PS50900
DomainMetalloPept_cat_dom

ADAMTS12 ADAMTS10 MMP15

1.41e-0381513IPR024079
Domain-

ADAMTS12 ADAMTS10 MMP15

1.41e-03815133.40.390.10
DomainADAM_spacer1

ADAMTS12 ADAMTS10

1.78e-0323512IPR010294
DomainHemopexin-like_dom

HPX MMP15

1.78e-0323512IPR000585
DomainADAM_spacer1

ADAMTS12 ADAMTS10

1.78e-0323512PF05986
DomainHemopexin

HPX MMP15

1.78e-0323512PF00045
DomainHEMOPEXIN

HPX MMP15

1.78e-0323512PS00024
Domain-

HPX MMP15

1.78e-03235122.110.10.10
DomainHEMOPEXIN_2

HPX MMP15

1.78e-0323512PS51642
DomainHemopexin-like_repeat

HPX MMP15

1.78e-0323512IPR018487
DomainHX

HPX MMP15

1.78e-0323512SM00120
DomainGAGE

GAGE5 GAGE6

1.94e-0324512PF05831
DomainPeptidase_M12B_ADAM-TS

ADAMTS12 ADAMTS10

1.94e-0324512IPR013273
DomainGAGE_fam

GAGE5 GAGE6

2.11e-0325512IPR008625
DomainZINC_PROTEASE

ADAMTS12 ADAMTS10 MMP15

2.43e-0398513PS00142
DomainPeptidase_M12B_N

ADAMTS12 ADAMTS10

5.08e-0339512IPR002870
DomainPep_M12B_propep

ADAMTS12 ADAMTS10

5.08e-0339512PF01562
DomainDISINTEGRIN_1

ADAMTS12 ADAMTS10

5.34e-0340512PS00427
DomainADAM_MEPRO

ADAMTS12 ADAMTS10

5.34e-0340512PS50215
DomainDISINTEGRIN_2

ADAMTS12 ADAMTS10

5.34e-0340512PS50214
DomainReprolysin

ADAMTS12 ADAMTS10

5.34e-0340512PF01421
DomainPeptidase_M12B

ADAMTS12 ADAMTS10

5.34e-0340512IPR001590
DomainCYSTEINE_SWITCH

ADAMTS12 MMP15

5.60e-0341512PS00546
DomainDisintegrin_dom

ADAMTS12 ADAMTS10

5.60e-0341512IPR001762
DomainPept_M10_metallopeptidase

ADAMTS12 MMP15

6.15e-0343512IPR001818
DomainC1-set

IGHG2 IGHG3

9.56e-0354512PF07654
Domainfn3

IL11RA FN1 IGSF9B

9.84e-03162513PF00041
DomainIGc1

IGHG2 IGHG3

1.02e-0256512SM00407
DomainIg_C1-set

IGHG2 IGHG3

1.10e-0258512IPR003597
DomainIg/MHC_CS

IGHG2 IGHG3

1.10e-0258512IPR003006
DomainRetrov_capsid_C

ADAMTS10 ERVK-5

1.13e-0259512IPR008916
DomainIG_MHC

IGHG2 IGHG3

1.17e-0260512PS00290
DomainTSP_1

ADAMTS12 ADAMTS10

1.28e-0263512PF00090
Pubmed

B-cell intrinsic regulation of antibody mediated immunity by histone H2A deubiquitinase BAP1.

IGHG2 IGHG3 BAP1

8.32e-08657338529289
Pubmed

Ontogenesis of the tear drainage system requires Prickle1-driven polarized basement membrane deposition.

FN1 ITGA6 CTNND1

1.18e-061357333144400
Pubmed

ADAMTS2 promotes radial migration by activating TGF-β signaling in the developing neocortex.

ADAMTS10 FN1 MMP15

1.87e-061557338871984
Pubmed

A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation.

SMG7 LIMD1 RBM33 EXOSC6 PLEC SPATS2 CTNND1 MCRIP2 PRRC2A

2.58e-0672457936232890
Pubmed

Structural and functional analysis of the actin binding domain of plectin suggests alternative mechanisms for binding to F-actin and integrin beta4.

ITGA6 PLEC

2.64e-06257212791251
Pubmed

Binding of integrin alpha6beta4 to plectin prevents plectin association with F-actin but does not interfere with intermediate filament binding.

ITGA6 PLEC

2.64e-06257210525545
Pubmed

β1 integrins regulate cellular behaviour and cardiomyocyte organization during ventricular wall formation.

FN1 ITGA6 CTNND1

6.29e-062257338794925
Pubmed

Effect of indole-3-carbinol on transcriptional profiling of wound-healing genes in macrophages of systemic lupus erythematosus patients: an RNA sequencing assay.

FN1 MMP15

7.91e-06357232517571
Pubmed

Plectin isoform-dependent regulation of keratin-integrin alpha6beta4 anchorage via Ca2+/calmodulin.

ITGA6 PLEC

7.91e-06357219419971
Pubmed

Structural basis of the interaction between integrin alpha6beta4 and plectin at the hemidesmosomes.

ITGA6 PLEC

7.91e-06357219242489
Pubmed

Epidermolysis Bullosa with Pyloric Atresia

ITGA6 PLEC

7.91e-06357220301336
Pubmed

Downregulation of HDPR1 is associated with poor prognosis and affects expression levels of p120-catenin and beta-catenin in nonsmall cell lung cancer.

DACT1 CTNND1

7.91e-06357220232357
Pubmed

A germline-specific class of small RNAs binds mammalian Piwi proteins.

YBX2 RBM33 RSPH6A BSN PRRC2A IPMK BAP1

8.77e-0645057716751776
Pubmed

The DNA sequence and analysis of human chromosome 13.

PRR20C PRR20D PRR20B PRR20E PRR20A

8.97e-0617057515057823
Pubmed

Nucleotide sequences of gene segments encoding membrane domains of immunoglobulin gamma chains.

IGHG2 IGHG3

1.58e-0545726283537
Pubmed

Distinction of the memory B cell response to cognate antigen versus bystander inflammatory signals.

IGHG2 IGHG3

1.58e-05457219703988
Pubmed

Somatic mutation in genes for the variable portion of the immunoglobulin heavy chain.

IGHG2 IGHG3

1.58e-0545726801765
Pubmed

Sequence analysis of cloned cDNA encoding part of an immunoglobulin heavy chain.

IGHG2 IGHG3

1.58e-054572113776
Pubmed

Highly specific anti-estradiol antibodies: structural characterisation and binding diversity.

IGHG2 IGHG3

1.58e-05457211812141
Pubmed

Multiple amino acid substitutions between murine gamma 2a heavy chain Fc regions of Ig1a and Ig1b allotypic forms.

IGHG2 IGHG3

1.58e-0545726794027
Pubmed

Sequences near the 3' secretion-specific polyadenylation site influence levels of secretion-specific and membrane-specific IgG2b mRNA in myeloma cells.

IGHG2 IGHG3

1.58e-0545722878362
Pubmed

IgG1 deficiency exacerbates experimental autoimmune myasthenia gravis in BALB/c mice.

IGHG2 IGHG3

1.58e-05457225867470
Pubmed

Sequence of the gamma 2b membrane 3' untranslated region: polya site determination and comparison to the gamma 2a membrane 3' untranslated region.

IGHG2 IGHG3

1.58e-0545721542303
Pubmed

Switch of CD4+ T cell differentiation from Th2 to Th1 by treatment with cathepsin B inhibitor in experimental leishmaniasis.

IGHG2 IGHG3

1.58e-0545729725203
Pubmed

Immunoglobulin diversity: analysis of the germ-line VH gene repertoire of the murine anti-GAT response.

IGHG2 IGHG3

1.58e-0545726306571
Pubmed

Nucleotide sequences of all the gamma gene loci of murine immunoglobulin heavy chains.

IGHG2 IGHG3

1.58e-0545729126488
Pubmed

Rearrangement of immunoglobulin gamma 1-chain gene and mechanism for heavy-chain class switch.

IGHG2 IGHG3

1.58e-0545726767246
Pubmed

Determination of the interface of a large protein complex by transferred cross-saturation measurements.

IGHG2 IGHG3

1.58e-05457212051834
Pubmed

Further evidence that BALB/c and C57BL/6 gamma 2a genes originate from two distinct isotypes.

IGHG2 IGHG3

1.58e-0545722510996
Pubmed

Spontaneous deletions in Ig heavy chain genes: flanking sequences influence splice site selection.

IGHG2 IGHG3

1.58e-0545721754385
Pubmed

Sialic acid residues are essential for the anaphylactic activity of murine IgG1 antibodies.

IGHG2 IGHG3

1.58e-05457219050247
Pubmed

The molecular and biochemical characterization of mutant monoclonal antibodies with increased antigen binding.

IGHG2 IGHG3

1.58e-0545721672339
Pubmed

The gamma 1 heavy chain gene includes all of the cis-acting elements necessary for expression of properly regulated germ-line transcripts.

IGHG2 IGHG3

1.58e-0545728683112
Pubmed

The IL-4 induced increase in the frequency of resting murine splenic B cells expressing germline Ig heavy chain gamma 1 transcripts correlates with subsequent switching to IgG1.

IGHG2 IGHG3

1.58e-0545728452816
Pubmed

Genes for immunoglobulin heavy chain and serum prealbumin protein are linked in mouse.

IGHG2 IGHG3

1.58e-054572807855
Pubmed

Identification of a gene locus for gamma-G-1 immunoglobulin H chains and its linkage to the H chain chromosome region in the mouse.

IGHG2 IGHG3

1.58e-0545724166666
Pubmed

Multiple B-cell epitope vaccine induces a Staphylococcus enterotoxin B-specific IgG1 protective response against MRSA infection.

IGHG2 IGHG3

1.58e-05457226201558
Pubmed

An autoimmune disease variant of IgG1 modulates B cell activation and differentiation.

IGHG2 IGHG3

1.58e-05457230287618
Pubmed

Switch transcripts in immunoglobulin class switching.

IGHG2 IGHG3

1.58e-0545727892607
Pubmed

Determination of the primary structure of a mouse G2a immunoglobulin. Identification of the disulfide bridges.

IGHG2 IGHG3

1.58e-0545724565406
Pubmed

Recognition of a cell-surface oligosaccharide of pathogenic Salmonella by an antibody Fab fragment.

IGHG2 IGHG3

1.58e-0545721713710
Pubmed

Structure of the constant and 3' untranslated regions of the murine Balb/c gamma 2a heavy chain messenger RNA.

IGHG2 IGHG3

1.58e-0545726777755
Pubmed

The roles of gamma 1 heavy chain membrane expression and cytoplasmic tail in IgG1 responses.

IGHG2 IGHG3

1.58e-0545729103199
Pubmed

Molecular cloning of mouse immunoglobulin heavy chain messenger ribonucleic acids coding for mu, alpha, gamma 1, gamma 2a, and gamma 3 chains.

IGHG2 IGHG3

1.58e-0545726249338
Pubmed

mRNA for surface immunoglobulin gamma chains encodes a highly conserved transmembrane sequence and a 28-residue intracellular domain.

IGHG2 IGHG3

1.58e-0545726804950
Pubmed

Gene conversion and polymorphism: generation of mouse immunoglobulin gamma 2a chain alleles by differential gene conversion by gamma 2b chain gene.

IGHG2 IGHG3

1.58e-0545726297797
Pubmed

Integrin-dependent organization and bidirectional vesicular traffic at cytotoxic immune synapses.

IGHG2 IGHG3

1.58e-05457219592272
Pubmed

Evolution of immunoglobulin subclasses. Primary structure of a murine myeloma gamma1 chain.

IGHG2 IGHG3

1.58e-05457298524
Pubmed

IgG1 protects against renal disease in a mouse model of cryoglobulinaemia.

IGHG2 IGHG3

1.58e-05457225363774
Pubmed

Attenuation of Trypanosoma brucei is associated with reduced immunosuppression and concomitant production of Th2 lymphokines.

IGHG2 IGHG3

1.58e-05457210720538
Pubmed

Determination of the primary structure of a mouse IgG2a immunoglobulin:amino-acid sequence of the Fc fragment. Implications for the evolution of immunoglobulin structure and function.

IGHG2 IGHG3

1.58e-0545724831970
Pubmed

Nucleotide sequences of class-switch recombination region of the mouse immunoglobulin gamma 2b-chain gene.

IGHG2 IGHG3

1.58e-0545727439686
Pubmed

Mutational deglycosylation of the Fc portion of immunoglobulin G causes O-sulfation of tyrosine adjacently preceding the originally glycosylated site.

IGHG2 IGHG3

1.58e-05457220621099
Pubmed

Immunoglobulin heavy constant gamma 1 silencing decreases tonicity-responsive enhancer-binding protein expression to alleviate diabetic nephropathy.

IGHG2 IGHG3

1.58e-05457238268239
Pubmed

Elucidation of the enigmatic IgD class-switch recombination via germline deletion of the IgH 3' regulatory region.

IGHG2 IGHG3

1.58e-05457224752300
Pubmed

Immunocytochemical studies of adhesion molecules on mouse UNK cells and their extracellular matrix ligands during mouse pregnancy.

FN1 ITGA6

1.58e-05457220201059
Pubmed

Variable-region-identical antibodies differing in isotype demonstrate differences in fine specificity and idiotype.

IGHG2 IGHG3

1.58e-05457215699144
Pubmed

Antibody epitopes on the neuraminidase of a recent H3N2 influenza virus (A/Memphis/31/98).

IGHG2 IGHG3

1.58e-05457212414967
Pubmed

On immunoglobulin heavy chain gene switching: two gamma 2b genes are rearranged via switch sequences in MPC-11 cells but only one is expressed.

IGHG2 IGHG3

1.58e-0545726278424
Pubmed

An Asia-specific variant of human IgG1 represses colorectal tumorigenesis by shaping the tumor microenvironment.

IGHG2 IGHG3

1.58e-05457235133976
Pubmed

Gene segments encoding transmembrane carboxyl termini of immunoglobulin gamma chains.

IGHG2 IGHG3

1.58e-0545726799207
Pubmed

Restriction fragment length polymorphism and evolution of the mouse immunoglobulin constant region gamma loci.

IGHG2 IGHG3

1.58e-0545728099342
Pubmed

Comparison of mouse immunoglobulin gamma 2a and gamma 2b chain genes suggests that exons can be exchanged between genes in a multigenic family.

IGHG2 IGHG3

1.58e-0545726787604
Pubmed

Shutdown of class switch recombination by deletion of a switch region control element.

IGHG2 IGHG3

1.58e-0545728438159
Pubmed

Passive anaphylaxis in mice with gamma-G antibodies. V. Competitive effects of different immunoglobulins and inhibition of reactions with antiglobulin sera.

IGHG2 IGHG3

1.58e-0545724098598
Pubmed

Sequence and polyadenylation site determination of the murine immunoglobulin gamma 2a membrane 3' untranslated region.

IGHG2 IGHG3

1.58e-0545722513486
Pubmed

Mouse immunoglobulin genes: a bacterial plasmid containing the entire coding sequence for a pre-gamma 2a heavy chain.

IGHG2 IGHG3

1.58e-0545726253932
Pubmed

Increased number of T cells and exacerbated inflammatory pathophysiology in a human IgG4 knock-in MRL/lpr mouse model.

IGHG2 IGHG3

1.58e-05457236763580
Pubmed

Ubiquitination of IgG1 cytoplasmic tail modulates B-cell signalling and activation.

IGHG2 IGHG3

1.58e-05457232006024
Pubmed

Immunoglobulin gamma 1 heavy chain gene: structural gene sequences cloned in a bacterial plasmid.

IGHG2 IGHG3

1.58e-0545726769752
Pubmed

Strong antigenic selection shaping the immunoglobulin heavy chain repertoire of B-1a lymphocytes in lambda 2(315) transgenic mice.

IGHG2 IGHG3

1.58e-05457212209645
Pubmed

Independent immunoglobulin class-switch events occurring in a single myeloma cell line.

IGHG2 IGHG3

1.58e-0545723921826
Pubmed

Mouse immunoglobulin allotypes: post-duplication divergence of gamma 2a and gamma 2b chain genes.

IGHG2 IGHG3

1.58e-0545726803173
Pubmed

Sequence of the cloned gene for the constant region of murine gamma 2b immunoglobulin heavy chain.

IGHG2 IGHG3

1.58e-054572117549
Pubmed

Cloning immunoglobulin gamma 2b chain gene of mouse: characterization and partial sequence determination.

IGHG2 IGHG3

1.58e-054572116231
Pubmed

The complete nucleotide sequence of mouse immunoglobin gamma 2a gene and evolution of heavy chain genes: further evidence for intervening sequence-mediated domain transfer.

IGHG2 IGHG3

1.58e-0545726262729
Pubmed

Pro-inflammatory pattern of IgG1 Fc glycosylation in multiple sclerosis cerebrospinal fluid.

IGHG2 IGHG3

1.58e-05457226683050
Pubmed

Multiple differences between the nucleic acid sequences of the IgG2aa and IgG2ab alleles of the mouse.

IGHG2 IGHG3

1.58e-0545726170065
Pubmed

Highly reduced binding to high and low affinity mouse Fc gamma receptors by L234A/L235A and N297A Fc mutations engineered into mouse IgG2a.

IGHG2 IGHG3

1.58e-05457225451975
Pubmed

Linkage of the four gamma subclass heavy chain genes.

IGHG2 IGHG3

1.58e-0545726264445
Pubmed

Genetic variants in the immunoglobulin heavy chain locus are associated with the IgG index in multiple sclerosis.

IGHG2 IGHG3

1.58e-05457223225573
Pubmed

Complete nucleotide sequence of immunoglobulin gamma2b chain gene cloned from newborn nouse DNA.

IGHG2 IGHG3

1.58e-0545726766534
Pubmed

Regulation of endodermal differentiation of human embryonic stem cells through integrin-ECM interactions.

FN1 ITGA6 MMP15

2.00e-053257323154389
Pubmed

Preneoplastic somatic mutations including MYD88L265P in lymphoplasmacytic lymphoma.

IGHG2 IGHG3

2.63e-05557235044826
Pubmed

FcgammaRIII (CD16)-deficient mice show IgG isotype-dependent protection to experimental autoimmune hemolytic anemia.

IGHG2 IGHG3

2.63e-0555729834201
Pubmed

IgG1 cytoplasmic tail is essential for cell surface expression in Igβ down-regulated cells.

IGHG2 IGHG3

2.63e-05557224548411
Pubmed

Exon shuffling generates an immunoglobulin heavy chain gene.

IGHG2 IGHG3

2.63e-0555726769120
Pubmed

Chromosomal location of the structural gene cluster encoding murine immunoglobulin heavy chains.

IGHG2 IGHG3

2.63e-0555726770027
Pubmed

The synthesis and processing of the messenger RNAs specifying heavy and light chain immunoglobulins in MPC-11 cells.

IGHG2 IGHG3

2.63e-055572103631
Pubmed

The extracellular matrix dimension of skeletal muscle development.

FN1 ITGA6

2.63e-05557221420400
Pubmed

Sequential class switching is required for the generation of high affinity IgE antibodies.

IGHG2 IGHG3

2.63e-05557222249450
Pubmed

CCAAT/enhancer binding protein β Induces Post-Switched B Cells to Produce Blimp1 and Differentiate into Plasma Cells.

IGHG2 IGHG3

2.63e-05557233163250
Pubmed

Protein arginine methyltransferase 1 regulates B cell fate after positive selection in the germinal center in mice.

IGHG2 IGHG3

2.63e-05557237310381
Pubmed

The FOXO1 Transcription Factor Instructs the Germinal Center Dark Zone Program.

IGHG2 IGHG3

2.63e-05557226620759
Pubmed

Expression of NrasQ61R and MYC transgene in germinal center B cells induces a highly malignant multiple myeloma in mice.

IGHG2 IGHG3

2.63e-05557232640012
Pubmed

Mouse models of human multiple myeloma subgroups.

IGHG2 IGHG3

2.63e-05557236853944
Pubmed

Repetitive sequences in class-switch recombination regions of immunoglobulin heavy chain genes.

IGHG2 IGHG3

2.63e-0555726781756
Pubmed

Cre-loxP-mediated gene replacement: a mouse strain producing humanized antibodies.

IGHG2 IGHG3

2.63e-0555727704573
Pubmed

YY1 Is Required for Germinal Center B Cell Development.

IGHG2 IGHG3

2.63e-05557227167731
Pubmed

Murine IgG1 complexes trigger immune effector functions predominantly via Fc gamma RIII (CD16).

IGHG2 IGHG3

2.63e-0555729743367
InteractionZNF683 interactions

PRR20C PRR20D PRR20B PRR20E PRR20A

3.13e-1110555int:ZNF683
InteractionCELF4 interactions

PRR20C PRR20D PRR20B PRR20E PRR20A

5.73e-1111555int:CELF4
InteractionBEND2 interactions

PRR20C PRR20D PRR20B PRR20E PRR20A

9.81e-1112555int:BEND2
InteractionPTTG2 interactions

PRR20C PRR20D PRR20B PRR20E PRR20A

2.47e-1014555int:PTTG2
InteractionMBNL3 interactions

PRR20C PRR20D PRR20B PRR20E PRR20A

5.36e-1016555int:MBNL3
InteractionPRR34 interactions

PRR20C PRR20D PRR20B PRR20E PRR20A

2.47e-0921555int:PRR34
InteractionTPRX1 interactions

PRR20C PRR20D PRR20B PRR20E PRR20A

2.47e-0921555int:TPRX1
InteractionC3orf36 interactions

PRR20C PRR20D PRR20B PRR20E PRR20A

7.91e-0926555int:C3orf36
InteractionZNF385C interactions

PRR20C PRR20D PRR20B PRR20E PRR20A

2.81e-0833555int:ZNF385C
InteractionHLX interactions

PRR20C PRR20D PRR20B PRR20E PRR20A

5.13e-0837555int:HLX
InteractionZCCHC14 interactions

PRR20C PRR20D PRR20B PRR20E PRR20A

5.13e-0837555int:ZCCHC14
InteractionTBX6 interactions

PRR20C PRR20D PRR20B PRR20E PRR20A

8.74e-0841555int:TBX6
InteractionFAM222B interactions

PRR20C PRR20D PRR20B PRR20E PRR20A

9.90e-0842555int:FAM222B
InteractionSAMD11 interactions

PRR20C PRR20D PRR20B PRR20E PRR20A

1.12e-0743555int:SAMD11
InteractionBICRAL interactions

PRR20C PRR20D PRR20B PRR20E PRR20A

1.12e-0743555int:BICRAL
InteractionDMRT3 interactions

PRR20C PRR20D PRR20B PRR20E FRS3 PRR20A

1.33e-0787556int:DMRT3
InteractionSP4 interactions

PRR20C PRR20D PRR20B PRR20E PRR20A

1.58e-0746555int:SP4
InteractionKRTAP19-1 interactions

PRR20C PRR20D PRR20B PRR20E PRR20A

1.77e-0747555int:KRTAP19-1
InteractionOXER1 interactions

PRR20C PRR20D PRR20B PRR20E PRR20A

2.43e-0750555int:OXER1
InteractionTRIM35 interactions

PRR20C PRR20D PRR20B LIMD1 PRR20E PRR20A

3.64e-07103556int:TRIM35
InteractionRIPPLY1 interactions

PRR20C PRR20D PRR20B PRR20E PRR20A

3.94e-0755555int:RIPPLY1
InteractionTIAL1 interactions

PRR20C PRR20D PRR20B FN1 PRR20E PRR20A PRRC2A

4.20e-07172557int:TIAL1
InteractionSH3RF1 interactions

PRR20C PRR20D PRR20B PRR20E PRR20A ARHGEF15

4.82e-07108556int:SH3RF1
InteractionZBTB32 interactions

PRR20C PRR20D PRR20B PRR20E PRR20A

5.16e-0758555int:ZBTB32
InteractionFAM9A interactions

PRR20C PRR20D PRR20B PRR20E PRR20A

5.62e-0759555int:FAM9A
InteractionCABP2 interactions

PRR20C PRR20D PRR20B PRR20E PRR20A

6.66e-0761555int:CABP2
InteractionC10orf55 interactions

PRR20C PRR20D PRR20B PRR20E PRR20A

9.17e-0765555int:C10orf55
InteractionSMAP1 interactions

PRR20C PRR20D PRR20B PRR20E PRR20A

1.07e-0667555int:SMAP1
InteractionTBX3 interactions

PRR20C PRR20D PRR20B PRR20E PRR20A

1.24e-0669555int:TBX3
InteractionYPEL3 interactions

PRR20C PRR20D PRR20B PRR20E FRS3 PRR20A

1.64e-06133556int:YPEL3
InteractionESRP1 interactions

PRR20C PRR20D PRR20B PRR20E PRR20A

2.14e-0677555int:ESRP1
InteractionPRR35 interactions

PRR20C PRR20D PRR20B PRR20E PRR20A

3.10e-0683555int:PRR35
InteractionRBPMS2 interactions

PRR20C PRR20D PRR20B PRR20E PRR20A

3.10e-0683555int:RBPMS2
InteractionPRR20B interactions

PRR20C PRR20D PRR20B PRR20E PRR20A

4.63e-0690555int:PRR20B
InteractionPRR20C interactions

PRR20C PRR20D PRR20B PRR20E PRR20A

4.63e-0690555int:PRR20C
InteractionPRR20D interactions

PRR20C PRR20D PRR20B PRR20E PRR20A

4.63e-0690555int:PRR20D
InteractionLASP1 interactions

PRR20C PRR20D PRR20B FN1 PRR20E PRR20A ARHGEF15

4.69e-06247557int:LASP1
InteractionRBM23 interactions

PRR20C PRR20D PRR20B PRR20E PRR20A

5.74e-0694555int:RBM23
InteractionNCK2 interactions

PRR20C PRR20D PRR20B PRR20E PRR20A DOK2 PRRC2A

6.90e-06262557int:NCK2
InteractionKRTAP19-5 interactions

PRR20C PRR20D PRR20B PRR20E PRR20A

7.40e-0699555int:KRTAP19-5
InteractionPRR20E interactions

PRR20C PRR20D PRR20B PRR20E PRR20A

8.16e-06101555int:PRR20E
InteractionNFYC interactions

PRR20C PRR20D PRR20B PRR20E PRR20A BAP1

8.55e-06177556int:NFYC
InteractionC1orf94 interactions

PRR20C PRR20D PRR20B PRR20E PRR20A

8.98e-06103555int:C1orf94
InteractionGTF2A1 interactions

PRR20C PRR20D PRR20B PRR20E PRR20A

9.41e-06104555int:GTF2A1
InteractionRHOXF2 interactions

PRR20C PRR20D PRR20B PRR20E PRR20A

9.41e-06104555int:RHOXF2
InteractionVENTX interactions

PRR20C PRR20D PRR20B PRR20E PRR20A

9.41e-06104555int:VENTX
InteractionVEZF1 interactions

PRR20C PRR20D PRR20B PRR20E PRR20A

9.86e-06105555int:VEZF1
InteractionGLIS2 interactions

PRR20C PRR20D PRR20B PRR20E PRR20A

1.03e-05106555int:GLIS2
InteractionHIVEP1 interactions

PRR20C PRR20D PRR20B SMG7 PRR20E PRR20A

1.14e-05186556int:HIVEP1
InteractionFOXH1 interactions

PRR20C PRR20D PRR20B PRR20E PRR20A

1.18e-05109555int:FOXH1
InteractionPRR20A interactions

PRR20C PRR20D PRR20B PRR20E PRR20A

1.18e-05109555int:PRR20A
InteractionNOTCH3 interactions

PRR20C PRR20D PRR20B PRR20E PRR20A

1.41e-05113555int:NOTCH3
InteractionMAGED1 interactions

PRR20C PRR20D PRR20B PRR20E PRR20A PRRC2A BAP1

1.49e-05295557int:MAGED1
InteractionEIF4ENIF1 interactions

PRR20C PRR20D PRR20B SMG7 PRR20E PRR20A PRRC2A

1.66e-05300557int:EIF4ENIF1
InteractionVAC14 interactions

PRR20C PRR20D PRR20B PRR20E PRR20A BAP1

1.76e-05201556int:VAC14
InteractionBHLHE40 interactions

PRR20C PRR20D PRR20B PRR20E PRR20A

1.81e-05119555int:BHLHE40
InteractionTHAP1 interactions

PRR20C PRR20D PRR20B PRR20E PRR20A

1.81e-05119555int:THAP1
InteractionHYPK interactions

PRR20C PRR20D PRR20B PRR20E PRR20A

2.30e-05125555int:HYPK
InteractionPITX1 interactions

PRR20C PRR20D PRR20B PRR20E PRR20A

2.48e-05127555int:PITX1
InteractionANKHD1 interactions

PRR20C PRR20D PRR20B PRR20E PRR20A BAP1

2.65e-05216556int:ANKHD1
InteractionCCNK interactions

PRR20C PRR20D PRR20B PRR20E PRR20A

2.99e-05132555int:CCNK
InteractionVPS37C interactions

PRR20C PRR20D PRR20B PRR20E PRR20A

4.10e-05141555int:VPS37C
InteractionFAM168A interactions

PRR20C PRR20D PRR20B PRR20E PRR20A

4.24e-05142555int:FAM168A
InteractionDAZL interactions

CASC3 SMG7 RBM33 MCRIP2 PRRC2A

4.69e-05145555int:DAZL
InteractionARID5A interactions

PRR20C PRR20D PRR20B PRR20E PRR20A

5.00e-05147555int:ARID5A
InteractionPOU6F2 interactions

PRR20C PRR20D PRR20B PRR20E PRR20A

5.17e-05148555int:POU6F2
InteractionTFG interactions

PRR20C PRR20D PRR20B PRR20E PRR20A BAP1

7.12e-05258556int:TFG
InteractionPATZ1 interactions

PRR20C PRR20D PRR20B PRR20E PRR20A

8.17e-05163555int:PATZ1
InteractionFKBP9 interactions

ADAMTS12 CASC3 FN1 LIMD1

9.34e-0587554int:FKBP9
InteractionBANP interactions

PRR20C PRR20D PRR20B TOX PRR20E PRR20A

1.05e-04277556int:BANP
InteractionPHF1 interactions

PRR20C PRR20D PRR20B PRR20E PRR20A

1.05e-04172555int:PHF1
InteractionCOL17A1 interactions

ITGA6 PLEC CTNND1

1.08e-0434553int:COL17A1
InteractionDVL3 interactions

PRR20C PRR20D PRR20B PRR20E PRR20A PLEC

1.12e-04280556int:DVL3
InteractionPOU2F1 interactions

PRR20C PRR20D PRR20B PRR20E PRR20A

1.14e-04175555int:POU2F1
InteractionVASP interactions

SMG7 FN1 LIMD1 AEBP1 FRS3 CEP170B

1.46e-04294556int:VASP
InteractionDAZAP2 interactions

PRR20C PRR20D PRR20B PRR20E PRR20A

1.52e-04186555int:DAZAP2
InteractionUBAP2L interactions

SMG7 FN1 MCRIP2 PRRC2A ARHGEF15 BAP1

1.57e-04298556int:UBAP2L
InteractionFOXP3 interactions

PRR20C PRR20D PRR20B PRR20E PRR20A PLEC PRRC2A

1.65e-04432557int:FOXP3
InteractionYTHDF2 interactions

CASC3 SMG7 FN1 MCRIP2 PRRC2A BAP1

2.01e-04312556int:YTHDF2
InteractionIGHV4-31 interactions

IGHG2 IGHG3

2.03e-048552int:IGHV4-31
InteractionZC3H10 interactions

PRR20C PRR20D PRR20B PRR20E PRR20A

2.13e-04200555int:ZC3H10
InteractionMATN2 interactions

FN1 IGHG2 IGHG3 HPX

2.56e-04113554int:MATN2
InteractionRBM42 interactions

PRR20C PRR20D PRR20B PRR20E PRR20A PRRC2A

2.76e-04331556int:RBM42
InteractionGRB2 interactions

CASC3 FN1 AEBP1 RBM33 FRS3 ITGA6 LRRK1 PLEC PRRC2A

3.05e-04806559int:GRB2
InteractionSIAH1 interactions

PRR20C PRR20D PRR20B PRR20E PRR20A

3.52e-04223555int:SIAH1
InteractionMCRIP2 interactions

CASC3 MCRIP2 PRRC2A

3.65e-0451553int:MCRIP2
InteractionGNG8 interactions

FN1 IGHG2 IGHG3 HPX

3.77e-04125554int:GNG8
InteractionIGF2BP2 interactions

YBX2 SMG7 FN1 MCRIP2 PRRC2A BAP1

4.13e-04357556int:IGF2BP2
InteractionDDX6 interactions

CASC3 SMG7 FN1 LIMD1 PLEC MCRIP2 PRRC2A

4.17e-04503557int:DDX6
InteractionR3HDM2 interactions

CASC3 SMG7 MCRIP2 PRRC2A

4.24e-04129554int:R3HDM2
InteractionTAC1 interactions

FN1 PLEC

4.74e-0412552int:TAC1
InteractionFXR1 interactions

SMG7 SPATS2 MCRIP2 PRRC2A ANKS3 CEP170B BAP1 ERVFRD-1

4.79e-04679558int:FXR1
InteractionSNRPB interactions

PRR20C PRR20D PRR20B FN1 PRR20E PRR20A BAP1

4.91e-04517557int:SNRPB
InteractionTOP3B interactions

DACT1 B4GALNT4 SMG7 RBM33 EXOSC6 LRRK1 PLEC DENND1A MCRIP2 PRRC2A CEP170B BAP1

5.02e-0414705512int:TOP3B
InteractionP2RX6 interactions

IGHG2 IGHG3 HPX

5.61e-0459553int:P2RX6
InteractionUBE2U interactions

FN1 IGHG2 IGHG3 HPX

5.63e-04139554int:UBE2U
InteractionPPP2R2B interactions

FN1 IGHG2 IGHG3 HPX PLEC

5.71e-04248555int:PPP2R2B
InteractionCASC3 interactions

CASC3 YBX2 MCRIP2 PRRC2A

6.10e-04142554int:CASC3
InteractionPRRC2A interactions

CASC3 GAGE5 SMG7 MCRIP2 PRRC2A BAP1

6.49e-04389556int:PRRC2A
InteractionADAMTS10 interactions

ADAMTS12 ADAMTS10

6.52e-0414552int:ADAMTS10
Cytoband13q21.1

PRR20C PRR20D PRR20B PRR20E PRR20A

3.15e-121357513q21.1
CytobandEnsembl 112 genes in cytogenetic band chr13q21

PRR20C PRR20D PRR20B PRR20E PRR20A

3.71e-07117575chr13q21
CytobandXp11.4-p11.2

GAGE5 GAGE6

2.26e-056572Xp11.4-p11.2
Cytoband14q32.33

IGHG2 IGHG3 CEP170B

2.90e-0322857314q32.33
Cytoband16p13.3

CORO7 MCRIP2 ANKS3

3.51e-0324457316p13.3
GeneFamilyADAM metallopeptidases with thrombospondin type 1 motif

ADAMTS12 ADAMTS10

5.09e-041932250
ToppCellrenal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

ADAMTS12 ADAMTS10 DACT1 YBX2 AEBP1 IGHG3

2.67e-08161506a7e09cf2ca6cd70d40d08440fe9c5ab9befa1b79
ToppCellrenal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

ADAMTS12 ADAMTS10 DACT1 YBX2 AEBP1 IGHG3

2.67e-0816150608920a716f6ec62538e361211455a30ad726d7be
ToppCellControl-B_cells-Plasma_cells|Control / group, cell type (main and fine annotations)

IGHG2 IGHG3 ITGA6 LRRK1 SPATS2 TMC3

4.38e-08175506fb23858cfce71509cafbe0d9728e678012ff2962
ToppCellCOVID-19-B_cells|COVID-19 / group, cell type (main and fine annotations)

TOX IGHG2 IGHG3 ITGA6 LRRK1 SPATS2

5.71e-081835062c016bb59f131a0e821853b085289a3583f0a729
ToppCellnucseq-Immune-Lymphocytic_B-Lymphocytic_B-Plasma|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2

IGHG2 IGHG3 ITGA6 LRRK1 SPATS2 TMC3

6.09e-081855063b77bc49cd3740acc025e162a36282ac09e12198
ToppCell-IPF_04|World / lung cells shred on cell class, cell subclass, sample id

ADAMTS12 ADAMTS10 AEBP1 IGHG2 IGHG3

3.29e-07128505dab10774bc0532a1664fd8ac2b54cffab01be55a
ToppCellTCGA-Ovary-Primary_Tumor-Ovarian_Carcinoma-Serous_Cystadenocarcinoma-6|TCGA-Ovary / Sample_Type by Project: Shred V9

ADAMTS12 ADAMTS10 DACT1 FN1 AEBP1

1.68e-06178505142879e9393e721f9b05a6bb46995c9d6d713c95
ToppCellCOVID-19-B_cells-Plasma_cells|COVID-19 / group, cell type (main and fine annotations)

IGHG2 IGHG3 ITGA6 LRRK1 SPATS2

1.93e-06183505130c109f63a5e3c8f83cb96e32f4addf513b6415
ToppCellParenchymal-NucSeq-Immune_Lymphocytic-B-B_plasma|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

IGHG3 ITGA6 LRRK1 SPATS2 TMC3

2.63e-061955050b0615553b9a1b60d666d074ce4260919e2d5642
ToppCellParenchymal-NucSeq-Immune_Lymphocytic-B-B_plasma-B_plasma_IgG|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

IGHG2 IGHG3 ITGA6 LRRK1 SPATS2

2.63e-06195505bb30ac112f8c42d113fa83a9b662e40c0685bb1e
ToppCellBronchial-NucSeq-Immune_Lymphocytic-B-B_plasma-B_plasma_IgG|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

IGHG2 IGHG3 ITGA6 LRRK1 SPATS2

2.69e-06196505fd18a9ae8401121ae276adff1a85d5f938e2df91
ToppCellControl-B_memory-3|Control / disease group and sub_cluster of B and Plasma cells(res = 0.5)

TOX IGHG2 IGHG3 ZDHHC14 CORO7

2.76e-06197505b86385c6c1d52ef4e3d855004d77afab61556978
ToppCellmLN-B_cell-B_cell_IgG_Plasma|B_cell / Region, Cell class and subclass

IGHG2 IGHG3 ITGA6 SPATS2 MMP15

2.76e-06197505bd1d01d6c49f68f5c85d84df96c90dd04b9de09b
ToppCellBronchial-NucSeq-Immune_Lymphocytic-B-B_plasma|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

IGHG3 ITGA6 LRRK1 SPATS2 TMC3

2.83e-06198505567fcf882c8612356946240843525b786f3c8dbe
ToppCellrenal_cortex_nuclei-Hypertensive_with+without-CKD-Immune-Lymphocytic_B-Plasma_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

IGHG2 IGHG3 LRRK1 SPATS2

2.62e-051535043724dd498b982be693ddff9cea7671863acf3ff8
ToppCellrenal_cortex_nuclei-Hypertensive_with+without-CKD-Immune-Lymphocytic_B-Plasma_Cell-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

IGHG2 IGHG3 LRRK1 SPATS2

2.62e-05153504d810fc5aff28449ce79b4148558b260878a2c696
ToppCellCOVID-19-kidney-Plasma|COVID-19 / Disease (COVID-19 only), tissue and cell type

IGHG2 IGHG3 LRRK1 SPATS2

3.12e-05160504f8d9e459976e711e9ad39ea2b6173140c0589d6e
ToppCellMild-Lymphoid-Plasma|Mild / Condition, Lineage, Cell class and cell subclass

AEBP1 IGHG2 IGHG3 SPATS2

3.12e-051605047fdb849f5caf5a127a2582326215e11f8eb4fa0e
ToppCellMild-Lymphoid-Plasma-|Mild / Condition, Lineage, Cell class and cell subclass

AEBP1 IGHG2 IGHG3 SPATS2

3.12e-05160504aa79848913910c01249d6cacf4ed53ec0e4f5c3d
ToppCellfacs-Lung-EPCAM-24m-Lymphocytic-Regulatory_T|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

B4GALNT4 TOX DOK2 TRIM59

3.69e-051675041a076a96d5d73d369453cd0dc8c81b70c1b824e7
ToppCellfacs-Lung-EPCAM-24m-Lymphocytic-regulatory_T_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

B4GALNT4 TOX DOK2 TRIM59

3.69e-0516750489e3aab0d2359d2a44b50db328e7c542f73888ea
ToppCelltumor_Lymph_Node_/_Brain-B_lymphocytes-Plasma_cells|B_lymphocytes / Location, Cell class and cell subclass

AEBP1 IGHG2 IGHG3 MMP15

3.87e-05169504150c08c7b1dc0f46173a7b8f6a3fc70d82906c0d
ToppCellfacs-Lung-24m-Hematologic-lymphocytic-regulatory_T_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

B4GALNT4 TOX DOK2 TRIM59

4.05e-051715044c36d0bf5fa3ddc2144f60769bb288ca4e4e20bc
ToppCellCOVID-19-kidney-Plasma|kidney / Disease (COVID-19 only), tissue and cell type

IGHG2 IGHG3 LRRK1 SPATS2

4.05e-05171504a59a054b8e119215f24dc5c80ad5a8094b3500f9
ToppCellfacs-Lung-24m-Hematologic-lymphocytic-regulatory_T_cell-regulatory_T_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

B4GALNT4 TOX DOK2 TRIM59

4.05e-05171504c5c1d23b4040a78991512bfcbe046c51f202d2cf
ToppCellPBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_B-B_cell-B_c04-SOX5-TNFRSF1B|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)

TOX AEBP1 IGHG2 IGHG3

4.05e-05171504a2938e56cb5749004317798dc7ac0f0c2d4d8ae0
ToppCellfacs-Spleen-nan-24m-Lymphocytic-Cd3e_T_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

B4GALNT4 TOX MAP6 DOK2

4.24e-05173504f2eeff86e7dc7f4e3c36f775777d56685d7096cf
ToppCelldroplet-Bladder-Unstain-18m-Hematologic-nan|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

TOX HS6ST2 DOK2 GMIP

4.33e-05174504773329bb91b97578df138446cf62101dd0dad758
ToppCellfacs-Spleen-nan-24m-Lymphocytic-CD4-positive,_alpha-beta_T_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

B4GALNT4 TOX MAP6 DOK2

4.33e-05174504096bc6f1889f2bbadfe1e1a3eb6ae569aaa2ee7d
ToppCellfacs-Diaphragm-Limb_Muscle-18m-Endothelial-nan|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

FRS3 ITGA6 MMP15 ARHGEF15

4.53e-05176504a3f27b5d7edf2d396c085efbe35305cfa0afa565
ToppCellPND07-28-samps-Mesenchymal-Myofibroblast-myofibroblast_-_mature_-_DCN|PND07-28-samps / Age Group, Lineage, Cell class and subclass

ADAMTS12 IL11RA DACT1 AEBP1

4.53e-0517650408f94b78b27feeb113dbfadbfa7fe34d08b2809b
ToppCellrenal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Lymphocytic_B-Plasma_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

IGHG2 IGHG3 LRRK1 SPATS2

4.73e-05178504f815bc76f98aaea2d9058173b02b6f36e45283ce
ToppCellrenal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Lymphocytic_B-Plasma_Cell-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

IGHG2 IGHG3 LRRK1 SPATS2

4.73e-05178504a0334764e865fea652c54b94bbc3b173f7cbc9fc
ToppCell5'-Adult-Appendix-Mesenchymal-fibroblastic-Stromal_2_(NPY+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract

ADAMTS12 DACT1 AEBP1 ZDHHC14

4.84e-05179504a1ea8daa0fe8900f5a04b555c77fe8ebdaa3908d
ToppCell5'-Airway_Nasal-Mesenchymal-Fibroblastic|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

ADAMTS12 DACT1 FN1 AEBP1

4.94e-05180504935c091bbcd6d10b81dc4731779e5bd98205c99f
ToppCell5'-Airway_Nasal-Mesenchymal|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

ADAMTS12 DACT1 FN1 AEBP1

4.94e-051805043dd384b7f3d9582b8fec9fe05100e466e6218b76
ToppCellBAL-Severe-Lymphocyte-B-B_cell-B_cell-B_activate-7|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

IGHG2 IGHG3 LRRK1 TRIM59

4.94e-051805049f4bbaf6435c23e3e552ae22be8ea7884314192d
ToppCellBAL-Severe-Lymphocyte-B-B_cell-B_cell|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

IGHG2 IGHG3 LRRK1 TRIM59

4.94e-05180504b465f2f8b0e9a2034a4f1272bb00c77439164dbf
ToppCellBAL-Severe-Lymphocyte-B-B_cell|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

IGHG2 IGHG3 LRRK1 TRIM59

4.94e-05180504c3c72531af5b9f7a7416727fe609dab5180e03b6
ToppCellrenal_medulla_nuclei-Hypertensive_with+without-CKD-Immune-Lymphocytic_B-Plasma_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

IGHG2 IGHG3 LRRK1 SPATS2

5.05e-051815046cdee2f56bc633b387b4dbbd78c624edbd712c24
ToppCellrenal_medulla_nuclei-Hypertensive_with+without-CKD-Immune-Lymphocytic_B-Plasma_Cell-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

IGHG2 IGHG3 LRRK1 SPATS2

5.05e-05181504b75b8b025257bccfe661fd0f92ab284b2a9c12ee
ToppCellkidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

ADAMTS12 DACT1 FN1 AEBP1

5.05e-05181504c6d2a13df3b74fade3b0c71e285b4c14c8e52413
ToppCellmetastatic_Brain-Fibroblasts-Myofibroblasts|metastatic_Brain / Location, Cell class and cell subclass

ADAMTS12 DACT1 FN1 AEBP1

5.05e-05181504bd0b5f74f9c81ec0f1592710774a4fdf33d9d5a9
ToppCellrenal_medulla_nuclei-Hypertensive_with+without-CKD-Immune-Lymphocytic_B|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

IGHG2 IGHG3 LRRK1 SPATS2

5.05e-051815045a4fe0eca7cbc9cbc8a2fdbe795a7c5f4052a659
ToppCellControl-Myeloid-DC1|Control / Condition, Lineage and Cell class

ADAMTS10 TOX LRRK1 SPATS2

5.05e-051815045a2a1f017ad23baed9972c68b4a46f4c618ef21a
ToppCellkidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

ADAMTS12 DACT1 FN1 AEBP1

5.05e-05181504c62b0a2422377ffadaab63edd538e87a06fa5017
ToppCellfacs-Brain_Non-Myeloid-Cerebellum-24m-Endothelial|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation

FN1 ITGA6 PLEC ARHGEF15

5.16e-05182504e6a734fb29105093d4cbfc3d0619a825b66da034
ToppCellfacs-Brain_Non-Myeloid-Cerebellum-24m-Endothelial-Endothelial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation

FN1 ITGA6 PLEC ARHGEF15

5.16e-05182504ccc313ecc0bfd8e2c6bb83a565b427b2310485ec
ToppCellfacs-Brain_Non-Myeloid-Cerebellum-24m-Endothelial-endothelial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation

FN1 ITGA6 PLEC ARHGEF15

5.16e-05182504b9f758961fb4a586ae86fa0b25edb8ce4616d644
ToppCell5'-Airway_Nasal-Mesenchymal-Fibroblastic-fibroblastic_type_2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

ADAMTS12 DACT1 FN1 AEBP1

5.27e-05183504803376f5260de83c48d4f7301278d078a32b3e6e
ToppCell5'-Airway_Nasal-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts-Peribronchial_fibroblasts_L.2.1.3.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

ADAMTS12 DACT1 FN1 AEBP1

5.27e-051835046d98973098c6d20c5305bce6a83a549a7d8dbfba
ToppCell5'-Airway_Nasal-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

ADAMTS12 DACT1 FN1 AEBP1

5.27e-05183504cc7f5a17b40e8d901885174922e5fa8877643071
ToppCellP07-Mesenchymal-mesenchymal_fibroblast-mesenchymal_alveolar_niche_cell|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase

IL11RA DACT1 FN1 AEBP1

5.38e-0518450401257e5c12e38b849fd3d9496c43ded666249ba5
ToppCell367C-Lymphocytic-Plasma_cell-|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)

IGHG2 IGHG3 ITGA6 SPATS2

5.38e-0518450414a5288d861260f63fbe0cbea3569cf643e7597e
ToppCell367C-Lymphocytic-Plasma_cell|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)

IGHG2 IGHG3 ITGA6 SPATS2

5.38e-05184504fc708a5c8a7b19fab973c72dc4383a7d30f8b59a
ToppCell5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts-Peribronchial_fibroblasts_L.2.1.3.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

ADAMTS12 DACT1 FN1 AEBP1

5.50e-0518550487c416d14ca6255bee39b16e7571553e36ee3069
ToppCellE17.5-Mesenchymal-mesenchymal_fibroblast-mesenchymal_alveolar_niche_cell|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase

IL11RA DACT1 FN1 AEBP1

5.50e-05185504c85bba1210f1d389add3e40be9b96abac40cf8c1
ToppCellPCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro2_(5)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung

IL11RA DACT1 FN1 TOX

5.50e-051855041ac6a32cc56d5d819649bdd99518e2ead0eead4c
ToppCellnormal_Lung-B_lymphocytes-MALT_B_cells|B_lymphocytes / Location, Cell class and cell subclass

IGHG2 IGHG3 ITGA6 SPATS2

5.61e-05186504f4d72463c5f287da6436287eda0a349b4185841e
ToppCellCOVID-19-lung-Plasma_cells_PRDM1/BLIMP_hi|lung / Disease (COVID-19 only), tissue and cell type

IGHG2 IGHG3 LRRK1 SPATS2

5.61e-0518650466676d9395172de5707e204826a1c9f73b448cca
ToppCellIPF-Lymphoid-B_Plasma|Lymphoid / Disease state, Lineage and Cell class

IGHG2 IGHG3 LRRK1 SPATS2

5.61e-05186504f9c21daf905d0bb0e0e769ca4bb069ea4b1ba25b
ToppCellControl-Lymphoid-B_Plasma|Lymphoid / Disease state, Lineage and Cell class

IGHG2 IGHG3 LRRK1 SPATS2

5.61e-05186504a08a50bff4e629588faa22440d57334b1df0e8df
ToppCellTCGA-Breast-Primary_Tumor-Breast_Carcinoma-Infiltrating_Ductal_Carcinoma-6|TCGA-Breast / Sample_Type by Project: Shred V9

ADAMTS12 DACT1 FN1 AEBP1

5.73e-05187504a96495803ba13fcfadd1d83b3cf5774f3fed0a20
ToppCell3'_v3-lymph-node_spleen-Lymphocytic_B_plasma-Plasma_cells|lymph-node_spleen / Manually curated celltypes from each tissue

IGHG2 IGHG3 LRRK1 SPATS2

5.85e-05188504c7b1807c96f87fbcd37739a159cf00f9a1ff5d71
ToppCellILEUM-non-inflamed-(5)_Plasma-(5)_IgG_plasma_cells|(5)_Plasma / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)

RBM33 IGHG2 IGHG3 ITGA6

5.85e-051885042156f1bc849ff1cb09ae296d13bedd913ae6b43b
ToppCellCOVID-19-lung-Plasma_cells_PRDM1/BLIMP_hi|COVID-19 / Disease (COVID-19 only), tissue and cell type

IGHG2 IGHG3 LRRK1 SPATS2

5.85e-05188504567b08514d9d84cbb40f9b7a679eec304f023428
ToppCellFibroblast-C|World / shred on cell class and cell subclass (v4)

IL11RA DACT1 FN1 AEBP1

5.97e-0518950458e0400fbab5a0755504275aef5cf7986149abab
ToppCellB_cells-Plasmablasts|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues

IGHG2 IGHG3 ITGA6 SPATS2

5.97e-0518950487cb7b6ba9fd57100d68e6eaeecd1ac6ab22d1c6
ToppCellCF-Lymphoid-B_cell|CF / Disease state, Lineage and Cell class

TOX IGHG2 IGHG3 ZDHHC14

6.10e-05190504374d8fd63c733178acab07682ed1519693efab45
ToppCell(2)_Fibroblasts-(21)_Fibro-2|World / Cell class and subclass of bone marrow stroma cells in homeostatis

FN1 AEBP1 ITGA6 PLEC

6.22e-051915045ee353c79055c08e8a3e2b43a0345bceb09f3890
ToppCellPND03-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

IL11RA DACT1 FN1 AEBP1

6.35e-05192504ad48c941a3ddfd9a5146bafc2209da577bb50531
ToppCellPND03-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

IL11RA DACT1 FN1 AEBP1

6.35e-0519250419b94f254d51b9bda3d9b7c6f85e27ecb58409c8
ToppCellNeuroendocrine|World / Class top

TOX MAP6 ZDHHC14 ARHGEF15

6.35e-051925040199da3ef9ddb6673e9aa41f346f374838aec182
ToppCell(5)_Plasma_IgG|World / Spleen cell shreds - cell class (v1) and cell subclass (v1)

IGHG2 IGHG3 ITGA6 SPATS2

6.48e-05193504a94ebb3bca62970d5d17b0234893918ee6b7b808
ToppCellSmart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-Mono-Mono_hypoxia-E|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

RNASE2 FN1 DOK2 IPMK

6.48e-05193504d9bb77214bb92e8392cf74e3bfdf177a96fd71ea
ToppCellCF-Lymphoid|CF / Disease state, Lineage and Cell class

TOX IGHG2 IGHG3 ZDHHC14

6.48e-0519350411de07d13a7da223990b56fa89ba7fc1c3dd0122
ToppCellFetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor

ADAMTS12 FN1 LIMD1 ZDHHC14

6.61e-0519450435f132cc38ac133be01834ed0946188aa0757eb4
ToppCellBronchial_Biopsy-Immune-B_cells|Immune / Tissue, Lineage and Cell class of Lung Cells from 10X

IGHG2 IGHG3 ITGA6 SPATS2

6.61e-05194504da0bdb9afeb9c4290cb10171836a045d3258ca97
ToppCellTCGA-Head_and_Esophagus-Primary_Tumor-Head_and_Neck_Carcinoma-Squamous_Cell_Carcinoma-8|TCGA-Head_and_Esophagus / Sample_Type by Project: Shred V9

ADAMTS12 DACT1 FN1 AEBP1

6.61e-0519450455b97095a7a17a312c616703d291738a0f806339
ToppCell(5)_Plasma-(5)_Plasma_IgG|(5)_Plasma / Spleen cell shreds - cell class (v1) and cell subclass (v1)

IGHG2 IGHG3 ITGA6

6.71e-0570503bfe020c111a27337ed4dc6ee59b74bc36b03eb49
ToppCellproximal-3-Hematologic-IGSF21+_Dendritic|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)

RNASE2 ZDHHC14 LRRK1 DENND1A

6.74e-051955048592d0332bc82a91e173680cfd1afc5ee189b289
ToppCellproximal-Hematologic-IGSF21+_Dendritic|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)

RNASE2 ZDHHC14 LRRK1 DENND1A

6.74e-05195504c48ff83c48342875f06c6c9e7d5bc6084a992848
ToppCellproximal-Hematologic-IGSF21+_Dendritic-3|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)

RNASE2 ZDHHC14 LRRK1 DENND1A

6.74e-05195504ae9d61011e95f7840cbb154738c79745fd29943e
ToppCell15-Trachea-Mesenchymal|Trachea / Age, Tissue, Lineage and Cell class

IL11RA DACT1 FN1 AEBP1

6.88e-051965047e178c76285e61c721c38d7a995ebf89dc428f9f
ToppCellmLN-B_cell-B_cell_IgG_Plasma|mLN / Region, Cell class and subclass

IGHG2 IGHG3 SPATS2 MMP15

6.88e-0519650403b79f237e4f7ebab46b277d05377569c6342cf7
ToppCellmLN-(2)_B_cell-(21)_B_cell_IgG_Plasma|mLN / shred on region, Cell_type, and subtype

IGHG2 IGHG3 SPATS2 MMP15

6.88e-05196504e8b12b046d42a58e6f4d9419ab05a5c55e764f34
ToppCellParenchymal-NucSeq-Immune_Lymphocytic-B|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

IGHG2 IGHG3 ITGA6 LRRK1

6.88e-05196504fc67d8aad1ec4d7f98ffe44fb103e230b9b42c35
ToppCell10x5'-lymph-node_spleen-Lymphocytic_T_CD4-Tnaive/CM_CD4_activated|lymph-node_spleen / Manually curated celltypes from each tissue

DACT1 ITGA6 IGSF9B DOK2

6.88e-05196504c945dc6c56c61732e065daaad7e6f48c02ee183c
ToppCell15-Trachea-Mesenchymal-Mesenchyme_SERPINF1-high|Trachea / Age, Tissue, Lineage and Cell class

IL11RA DACT1 FN1 AEBP1

6.88e-0519650454aefcebf13704f51de84379e2e22ec0734b9461
ToppCelldroplet-Bladder-nan-24m-Epithelial-bladder_cell|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

IL11RA DACT1 FN1 AEBP1

6.88e-0519650483669ffdfe663885086571ccb0809f62aaba9752
ToppCellLung_Parenchyma-Severe-Lymphocyte-B-Plasmablast|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

IGHG2 IGHG3 ITGA6 SPATS2

7.01e-05197504365654a344bfdd2533cfcbed05063427b40f47b9
ToppCell3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

ADAMTS12 DACT1 FN1 AEBP1

7.01e-0519750494a9603cbd3516fbcce871909693b88f20d41713
ToppCellLung_Parenchyma-Severe-Lymphocyte-B-Plasmablast-Plasmablast|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09)

IGHG2 IGHG3 ITGA6 SPATS2

7.01e-051975049936dc179aa0cf8aadf77946b26c09ad33848dc2
ToppCellCOVID-19_Severe|World / Disease group, lineage and cell class

RNASE2 IGHG2 IGHG3 ITGA6

7.01e-05197504f0824f98269bdcd8463873beaf222df8f0caa468
ToppCell10x3'2.3-week_17-19-Endothelial-stroma-tip_EC|week_17-19 / cell types per 3 fetal stages;per 3',per 5'

ITGA6 CTNND1 MMP15 ARHGEF15

7.01e-05197504b212ff28ca2d1fea4140f186ab90941bdca21249
ToppCellLung_Parenchyma-Severe-Lymphocyte-B|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09)

IGHG2 IGHG3 ITGA6 SPATS2

7.01e-051975049e0850b6bb952757c74ba816e30006199e562bfa
ToppCellParenchyma_COVID-19-Immune-TX-Plasma_cells|Parenchyma_COVID-19 / Sample group, Lineage and Cell type

IGHG2 IGHG3 ITGA6 SPATS2

7.01e-051975043259d7ce3e6dde1beda8b534bdf7ff5c7fc1a46c
ToppCellPBMC-Severe|PBMC / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

RNASE2 IGHG2 IGHG3 ITGA6

7.01e-051975043ff23b86d310ace388d2efb3ee73dd47c46f363e
ToppCellLung_Parenchyma-Severe-Lymphocyte-B-Plasmablast-Plasmablast-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

IGHG2 IGHG3 ITGA6 SPATS2

7.01e-051975045474774c2ff7a13ec1a020e2fef4efa72e34727b
ToppCell10x3'2.3-week_17-19-Endothelial|week_17-19 / cell types per 3 fetal stages;per 3',per 5'

ITGA6 CTNND1 MMP15 ARHGEF15

7.15e-051985042630a7a6e56febe5c0b0bde70dd7292fa1650c47
Diseaseobsolete aging, cognition

PRR20C PRR20D PRR20B PRR20E PRR20A

4.56e-1115535EFO_0003925, GO_0007568
Diseaset-tau:beta-amyloid 1-42 ratio measurement

PRR20C PRR20D PRR20B PRR20E PRR20A

1.27e-0766535EFO_0007708
Diseasemosaic loss of chromosome Y measurement

PRR20C PRR20D PRR20B PRR20E PRR20A

3.34e-0780535EFO_0007783
DiseaseTinnitus, wellbeing measurement

PRR20C PRR20D PRR20B PRR20E PRR20A

8.32e-0796535EFO_0007869, HP_0000360
DiseaseEpidermolysis bullosa with pyloric atresia

ITGA6 PLEC

9.49e-063532C1856934
Diseasetelomere length

PRR20C PRR20D PRR20B PRR20E PRR20A PRRC2A

2.05e-05313536EFO_0004505
Diseaseapolipoprotein L1 measurement

CYP11B1 HPX

9.25e-0425532EFO_0021854
Diseaset-tau measurement

ADAMTS12 ZDHHC14 CEP170B

1.52e-03126533EFO_0004760

Protein segments in the cluster

PeptideGeneStartEntry
DFEYIRRQKQPRPPP

AEBP1

246

Q8IUX7
VGRSRVPVRPPQQYS

BAP1

381

Q92560
VPVGGYEEVPRVPRR

ARHGEF15

226

O94989
RQGEPYPERPKGPVQ

CEP170B

186

Q9Y4F5
RPPRQDFVYPTVAPG

ADAMTS10

456

Q9H324
YGRQPQPGPVRFPDR

ADAMTS12

26

P58397
QGQQPVFPRERPVRP

RBM33

516

Q96EV2
PQGLRVESVPGYPRR

IL11RA

221

Q14626
PVPAPRPRGQEGEYA

DOK2

286

O60496
QRPEPSCRPRSEYQP

MAP6

131

Q96JE9
AAGQPPYPPQEQRSR

LIMD1

121

Q9UGP4
GTPGYQAPEIRPRIV

LRRK1

1426

Q38SD2
SRQPVKYPRGGVRPV

GMIP

866

Q9P107
RRIRGPEESQPPQLY

EXOSC6

6

Q5RKV6
GPPVQPRATERPDQY

MMP15

351

P51511
VQTAPYRSGPRGRPR

BSN

1781

Q9UPA5
VRVYRPRSGPEPLQE

CORO7

661

P57737
PDQFVYKTRPPREQP

ITGA6

271

P23229
QLQPPPRGPRELEFY

IPMK

76

Q8NFU5
PIAYVKPFRRQPPAR

PRR20D

51

P86480
PIAYVKPFRRQPPAR

PRR20A

51

P86496
PIAYVKPFRRQPPAR

PRR20B

51

P86481
ALQGRAPYPQPPTVR

ERVK-5

236

Q9HDB9
APQGREPYPQPPTRR

ERVK-8

236

P62685
RYSSQRQRPVPEPPA

CASC3

521

O15234
RGRRENVGLYPAPVP

DACT1

696

Q9NYF0
QVRPGPVYKPAPARN

C5orf60

131

A6NFR6
RHRPRPYPPNVGEEI

FN1

2161

P02751
RPGPEPPRQLNYIQV

FRS3

406

O43559
WPRPRRYVQPPEVIG

GAGE6

11

Q13070
GRNPALFPRPERYNP

CYP11B1

411

P15538
GPRPVQYVERTPNPR

MCRIP2

121

Q9BUT9
GGRAPRPRYEQAPPR

ANKS3

281

Q6ZW76
VPSPEQPQPYRTLRE

DENND1A

521

Q8TEH3
FEPPRQPERGAPVRT

HS6ST2

11

Q96MM7
QPREPQVYTLPPSRE

IGHG2

221

P01859
GQPREPQVYTLPPSR

IGHG3

271

P01860
WPRPRRYVQPPEVIG

GAGE5

11

Q13069
PSRQDVYGPQPQVRV

CTNND1

251

O60716
PVRGEVPPRYPRDVR

HPX

211

P02790
PYPERPAQQPPGRRT

RSPH6A

6

Q9H0K4
RQYASRVPRQPPSPQ

TMC3

926

Q7Z5M5
PIAYVKPFRRQPPAR

PRR20C

51

P86479
RSPGVFRPEQDPVPR

SMG7

896

Q92540
SPRPPTRYEPQRVNS

PRRC2A

1511

P48634
PIAYVKPFRRQPPAR

PRR20E

51

P86478
RDQRRDPPQYPVVPV

RNASE2

141

P10153
PPPKVYVTRVRPGQR

B4GALNT4

521

Q76KP1
PYQPLREVLPGNRRG

SPATS2

436

Q86XZ4
GSRPEPQRPRNRPYF

YBX2

311

Q9Y2T7
IRPQYSDPRQARQPG

ZC3H6

1141

P61129
PIPIYGNSPLPRVRR

ERVFRD-1

336

P60508
YEPQPRPRPSPRQAR

IGSF9B

1171

Q9UPX0
PPKRGPLPTEEQRVY

PLEC

126

Q15149
RRGYIQPDTPQPAAP

ZDHHC14

326

Q8IZN3
VPERRIPNRYLGQPS

XPNPEP3

36

Q9NQH7
QGNPTSPRYNPRPLE

nan

156

Q5PR19
EYVRSGCRNPPPQPV

TOX

491

O94900
QRPLPEVQPVEIYPR

TRIM59

266

Q8IWR1